← Human Trials & Peer-Reviewed Studies
Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
Plain-language guide to PMID 25962885 (2015): pilot randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 25962885
- Journal
- Trials
- Year
- 2015
- Study type
- Randomized Controlled Trial
- Authors
- Kennedy CC et al. (19 authors)
- DOI
- 10.1186/s13063-015-0720-3
- Registered trial
- NCT01398527
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Few studies have systematically examined whether knowledge translation (KT) strategies can be successfully implemented within the long-term care (LTC) setting.
Who Took Part
By PubMed's age tags, the people studied were older adults and people over 80, both men and women.
How the Study Was Run
The design is described as randomized and pilot.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.
The researchers conducted a pilot, cluster randomized controlled trial in 40 LTC homes (21 control; 19 intervention) in Ontario, Canada.
Control homes did not receive any additional intervention.
Data were analyzed using the generalized estimating equations technique accounting for clustering within the LTC homes.
What Was Measured
The subject headings attached to it are Accidental Falls, Bone Density Conservation Agents, Calcium, Cooperative Behavior, Dietary Supplements, Drug Prescriptions and Education, Medical, Continuing.
What This Means in Plain Language
The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2015 (Trials), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.